FDA
-
-
-
-
-
-
-
Chiasma Inc. (CHMA) Announces Submission of MAA for MYCAPSSA to European Medicines Agency
-
-
-
-
-
-
-
Amryt Reports Record Q1 2021 Financial and Operating Results
-
-
-
-
-
-
-
After-Hours Stock Movers 03/22: (BLFS) (CHMA) (PTGX) Higher; (IONS) (RAVN) (QS) Lower (more...)
-
-
-
-
-
-
-
Chiasma to Participate in the H.C. Wainwright Global Life Sciences Conference
-
-
-
-
-
-
-
Chiasma to Host an Expert Panel on Acromegaly and the MPOWERED® Phase 3 Trial Results
-
-
-
-
-
-
-
Chiasma Inc. (CHMA) Announces Planned Transition of Former CEO
-
-
-
-
-
-
-
Chiasma Reports Second Quarter 2020 Results and Significant Progress on Launch Preparedness
-
322,084 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

